Exousia Bio, Inc. Asset Impairment Charges
Exousia Bio, Inc. (LMMY) reported Asset Impairment Charges of $3.46 thousand for the 12-month period ending 2025-05-31, per its 10-K filed 2025-10-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2025-10-17
- Exousia Bio, Inc. asset impairment charges for fiscal 2025 was $3.46K.
- Exousia Bio, Inc. asset impairment charges for fiscal 2024 was $0.00.
| Period end | Asset Impairment Charges 12 month |
|---|---|
| 2025-05-31 | $3.46K 10-K · filed 2025-10-17 |
| 2024-05-31 | $0.00 10-K · filed 2025-10-17 |